These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 19968523)

  • 1. Measuring participation in children with Gilles de la Tourette syndrome: a pilot study with ICF-CY.
    Meucci P; Leonardi M; Zibordi F; Nardocci N
    Disabil Rehabil; 2009; 31 Suppl 1():S116-20. PubMed ID: 19968523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social and emotional adjustment in children affected with Gilles de la Tourette's syndrome: associations with ADHD and family functioning. Attention Deficit Hyperactivity Disorder.
    Carter AS; O'Donnell DA; Schultz RT; Scahill L; Leckman JF; Pauls DL
    J Child Psychol Psychiatry; 2000 Feb; 41(2):215-23. PubMed ID: 10750547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of ICF to describe functioning and disability in children with brain tumours.
    Ajovalasit D; Vago C; Usilla A; Riva D; Fidani P; Serra A; Gentile S; Massimino M; Biassoni V; Leonardi M
    Disabil Rehabil; 2009; 31 Suppl 1():S100-7. PubMed ID: 19968521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of quality of life in children with Gilles de la Tourette syndrome.
    Bernard BA; Stebbins GT; Siegel S; Schultz TM; Hays C; Morrissey MJ; Leurgans S; Goetz CG
    Mov Disord; 2009 May; 24(7):1070-3. PubMed ID: 19306279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control of inner speech and Gilles de la Tourette's syndrome].
    Vercueil L
    Encephale; 2003; 29(5):460-2. PubMed ID: 14615696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gilles de la Tourette syndrome-quality of life scale (GTS-QOL): development and validation.
    Cavanna AE; Schrag A; Morley D; Orth M; Robertson MM; Joyce E; Critchley HD; Selai C
    Neurology; 2008 Oct; 71(18):1410-6. PubMed ID: 18955683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functioning and disability in patients with Angelman syndrome: utility of the International Classification of functioning disability and health, children and youth adaptation framework.
    Bonanni P; Gobbo A; Nappi S; Moret O; Nogarol A; Santin M; Randazzo G; Martinuzzi A
    Disabil Rehabil; 2009; 31 Suppl 1():S121-7. PubMed ID: 19968524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight years of ICF in Italy: principles, results and future perspectives.
    Francescutti C; Martinuzzi A; Leonardi M; Kostanjsek NF
    Disabil Rehabil; 2009; 31 Suppl 1():S4-7. PubMed ID: 19968532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding disability in Tourette syndrome.
    Pringsheim T; Lang A; Kurlan R; Pearce M; Sandor P
    Dev Med Child Neurol; 2009 Jun; 51(6):468-72. PubMed ID: 19018838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children with Tourette syndrome: results of psychological tests given prior to drug treatment.
    Ferrari M; Matthews WS; Barabas G
    J Dev Behav Pediatr; 1984 Jun; 5(3):116-9. PubMed ID: 6588056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma--quality of life for Swedish children.
    Rydström I; Dalheim-Englund AC; Holritz-Rasmussen B; Möller C; Sandman PO
    J Clin Nurs; 2005 Jul; 14(6):739-49. PubMed ID: 15946282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of functioning in patients with head and neck cancer according to the International Classification of Functioning, Disability, and Health (ICF): a multicenter study.
    Tschiesner U; Linseisen E; Baumann S; Siedek V; Stelter K; Berghaus A; Cieza A
    Laryngoscope; 2009 May; 119(5):915-23. PubMed ID: 19358200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gilles de la Tourette syndrome: a principal component factor analytic study of a large pedigree.
    Robertson MM; Cavanna AE
    Psychiatr Genet; 2007 Jun; 17(3):143-52. PubMed ID: 17417057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICF and ICF-CY for an innovative holistic approach to persons with chronic conditions.
    Leonardi M; Martinuzzi A
    Disabil Rehabil; 2009; 31 Suppl 1():S83-7. PubMed ID: 19968542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The English Version of the Gilles de la Tourette Syndrome-Quality of Life Scale for Children and Adolescents (C&A-GTS-QOL).
    Su MT; McFarlane F; Cavanna AE; Termine C; Murray I; Heidemeyer L; Heyman I; Murphy T
    J Child Neurol; 2017 Jan; 32(1):76-83. PubMed ID: 27686095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical variability of the Gilles de la Tourette's syndrome: the heterogeneity of the classical syndrome].
    Smirnov AIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(3):61-6. PubMed ID: 2163173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subjective quality of life in children with Tourette syndrome].
    Yi MJ; Sun ZY; Ran N
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Sep; 13(9):732-5. PubMed ID: 21924023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A measure of functional impairment in youth with Tourette's syndrome.
    Storch EA; Lack CW; Simons LE; Goodman WK; Murphy TK; Geffken GR
    J Pediatr Psychol; 2007 Sep; 32(8):950-9. PubMed ID: 17522110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gilles de la Tourette's syndrome].
    Marneros A
    Fortschr Neurol Psychiatr; 1984 Jul; 52(7):250-7. PubMed ID: 6592133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.